Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of Preemptive Genotyping in Preventing Serious Adverse Drug Events in South Korean Patients.

Drug safety - 1 Jan 2017

Kim Grace Juyun, Lee Soo Youn, Park Ji Hye, Ryu Brian Y, Kim Ju Han

Abstract excerpt

INTRODUCTION: Preemptive and multi-variant genotyping is suggested to improve the safety of patient drug therapy. The number of South Koreans who would benefit from this approach is unknown. OBJECTIVE: We aimed to quantify the number of patients who may experience serious adverse drug events (ADEs) due to high-risk pharmacogenetic variants and who may benefit from preemptive genotyping. METHODS: The health claims...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asian People
Share to Datasets as Topic
Share to Drug-Related Side Effects and Adverse Reactions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Markers

Share to Genotyping Techniques

Share to Pharmacogenetics

Share to Prevalence

Share to Republic of Korea

Source

Identifiers

PMID: 27638658
DOI: 10.1007/s40264-016-0454-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of Preemptive Genotyping in Preventing Serious Adverse Drug Events in South Korean Patients.PMID 27638658Read ↗

Estimation of the benefit from pre-emptive genotyping based on the nationwide cohort data in South Korea.Semantic proximity Read ↗

Use of Pharmacogenetic Drugs by the Dutch PopulationSemantic proximity Read ↗

A retrospective analysis of preemptive pharmacogenomic testing in 22,918 individuals from China.Semantic proximity Read ↗

Improving Therapeutic Odyssey: Preemptive Pharmacogenomics Utility in Patient Care.Semantic proximity Read ↗

Digging up the human genome: current progress in deciphering adverse drug reactions.Semantic proximity Read ↗

Genomics of Adverse Drug Reactions.Semantic proximity Read ↗

Actionable pharmacogenetic variants in Hong Kong Chinese exome sequencing data and projected prescription impact in the Hong Kong population.Semantic proximity Read ↗

Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping.Semantic proximity Read ↗

Clinical application of pharmacogenomics: the example of HLA-based drug-induced toxicity.Semantic proximity Read ↗

Implementation of pre‐emptive testing of a pharmacogenomic panel in clinical practice: Where do we stand?Semantic proximity Read ↗

Clinical Impact of Pharmacogenetic Risk Variants in a Large Chinese CohortSemantic proximity Read ↗

Progress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.